These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2436774)
41. Relation between ultrastructural presence of CEA using peroxidase-antiperoxidase (PAP) method and tissue and serum levels of CEA in patients with breast cancer. Grzanka A; Cetnarowski L; Domaniewski J Folia Histochem Cytobiol; 1991; 29(4):131-4. PubMed ID: 1819536 [TBL] [Abstract][Full Text] [Related]
42. Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience. Gilchrist KW; Kalish L; Gould VE; Hirschl S; Imbriglia JE; Levy WM; Patchefsky AS; Pickren J; Roth JA; Schinella RA Cancer; 1985 Jul; 56(2):351-5. PubMed ID: 3891068 [TBL] [Abstract][Full Text] [Related]
43. Carcinoembryonic antigen expression and patient survival in carcinoma of the breast. Halter SA; Fraker LD; Parmenter M; Dupont WD Oncology; 1984; 41(5):297-302. PubMed ID: 6382094 [TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma-CEA, and biochemical receptor status. Böcker W; Schweikhart G; Pollow K; Kreienberg R; Klaubert A; Schröder S; Mitze M; Bahnsen J; Stegner HE Pathol Res Pract; 1985 Nov; 180(5):490-7. PubMed ID: 3001680 [TBL] [Abstract][Full Text] [Related]
45. [Immunohistochemical studies on bladder tumours. Evaluation by CEA, ferritin, beta 2-MG, keratin and glycogen]. Onodera Y Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1649-53. PubMed ID: 1704938 [TBL] [Abstract][Full Text] [Related]
46. [A study of DNA content in relation to histological type, ER and CEA in primary breast carcinoma]. Huang XC Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):264-7. PubMed ID: 1964400 [TBL] [Abstract][Full Text] [Related]
47. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Alberti O; Brentani MM; Goes JC; Lemos LB; Torloni H Cancer; 1986 Mar; 57(5):1042-5. PubMed ID: 3002592 [TBL] [Abstract][Full Text] [Related]
48. CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parameters. Duffy MJ; O'Connell M; O'Sullivan F; McKenna B; Allen MA; McDonnell L Cancer; 1983 Jan; 51(1):121-3. PubMed ID: 6295590 [TBL] [Abstract][Full Text] [Related]
49. Correlation of estrogen receptor protein and carcinoembryonic antigen with lymphnodal metastasis in breast carcinoma. Khemani AK; Kapila K; Sundaram KR; Verma K J Surg Oncol; 1988 Apr; 37(4):239-41. PubMed ID: 3361915 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis. Gaglia P; Caldarola B; Bussone R; Potente F; Lauro D; Jayme A; Caldarola L Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1151-5. PubMed ID: 3416899 [TBL] [Abstract][Full Text] [Related]
51. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Allred DC; Bustamante MA; Daniel CO; Gaskill HV; Cruz AB Arch Surg; 1990 Jan; 125(1):107-13. PubMed ID: 1688490 [TBL] [Abstract][Full Text] [Related]
52. Comparative study of CEA staining in gastric and colorectal cancer tissues. Kojima O; Tanioku T; Kitagawa N; Uehara Y; Majima T; Ikeda E; Iwai N; Fujita Y; Majima S Gastroenterol Jpn; 1984 Feb; 19(1):18-23. PubMed ID: 6202582 [TBL] [Abstract][Full Text] [Related]
53. Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor. Mansour EG; Hastert M; Park CH; Koehler KA; Petrelli M Cancer; 1983 Apr; 51(7):1243-8. PubMed ID: 6825048 [TBL] [Abstract][Full Text] [Related]
54. Histochemical demonstration of endogenous estrogen in breast carcinomas: biochemical and clinical correlation. Katayama I; Shimizu M; Miura M; Maruyama M; Kobayashi M; Iino Y; Izuo M; Wakatsuki S Virchows Arch A Pathol Anat Histopathol; 1984; 402(4):353-9. PubMed ID: 6426145 [TBL] [Abstract][Full Text] [Related]
55. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. Smith SR; Howell A; Minawa A; Morrison JM Br J Cancer; 1982 Nov; 46(5):757-64. PubMed ID: 6756459 [TBL] [Abstract][Full Text] [Related]
56. Tissue carcinoembryonic antigen and estrogen receptor in human breast cancer. Hartfiel R; Lopes JD; Lopes MT; Brentani MM Int J Cancer; 1985 Feb; 35(2):165-7. PubMed ID: 3882579 [TBL] [Abstract][Full Text] [Related]
57. [Cytosol CEA: a prognosis factor in breast carcinoma? (personal experience with 76 cases)]. Amadori D; Frassineti L; Riccobon A; Volpi A; Vasini M; Nanni O; Zoli W; Pallotti G J Nucl Med Allied Sci; 1990; 34(4 Suppl):25-6. PubMed ID: 2092127 [No Abstract] [Full Text] [Related]
58. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer. Bezwoda W; Derman D; Bothwell T; MacPhil P; Levin J; De Moor N Cancer; 1981 Oct; 48(7):1623-8. PubMed ID: 7284963 [TBL] [Abstract][Full Text] [Related]
60. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)]. Wurster K; Heberling D; Rapp W Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]